INCARA PHARMACEUTICALS CORP 4
4 · INCARA PHARMACEUTICALS CORP · Filed Jul 30, 2003
Insider Transaction Report
Form 4
GAMMANS RICHARD E SR
Executive VP, R&D
Transactions
- Award
Incentive Stock Option (right to buy)
2003-07-28+1,575,489→ 1,780,772 totalExercise: $0.15Exp: 2013-07-28→ Common Stock (1,575,489 underlying) - Award
Incentive Stock Option (right to buy)
2003-07-28+205,283→ 1,780,772 totalExercise: $0.15Exp: 2013-07-28→ Common Stock (205,283 underlying) - Award
Non-Qualified Stock Option (right to buy)
2003-07-28+74,511→ 74,511 totalExercise: $0.15Exp: 2013-07-28→ Common Stock (74,511 underlying)
Footnotes (3)
- [F1]Exercisable ratably over 12 months commencing July 28, 2003.
- [F2]229,166 shares exercisable ratably over 5 months commencing July 28, 2003, 475,489 shares exercisable ratably over 12 months commencing January 28, 2004 and 870,834 shares exercisable ratably over 19 months commencing January 28, 2005, based on continued consulting or employment with the Company.
- [F3]Exercisable ratably over 12 months commencing January 28, 2004, based on continued consulting or employment with the Company.